Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

516 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Performance of whole genome sequencing for respiratory syncytial virus: insights from the first external quality assessment, France, 2024.
Moisan A, Regue H, Rahou Y, Gaymard A, Oblette A, Avon L, Bergaud N, Chalvignac R, Le Hingrat Q, Burrel S, Jary A, Colson P, Cappy P, Deroche L, Brodard V, Pronier C, Alessandri-Gradt E, Salmona M, Chollet L, Trémeaux P, Handala L, Fourati S, Lina B, Casalegno JS, Rameix-Welti MA, Josset L, Bal A; collaborative group; Bichat; Houhou N, Guilbaud R, Saint-Joannis T; Bordeaux; La Pitié-Salpêtrière; Marseille; Mondor; Reims; Rennes; Rouen; Saint-Louis; Toulon; Poggi C, Toyer AL, Domine M, Gardan V; Toulouse; Carcenac R, Demmou S, Latour J, Vellas C; Tours; Lyon; Pasteur; ANRS-MIE Technology working group. Moisan A, et al. Among authors: salmona m. Clin Microbiol Infect. 2024 Dec 24:S1198-743X(24)00605-0. doi: 10.1016/j.cmi.2024.12.018. Online ahead of print. Clin Microbiol Infect. 2024. PMID: 39725080 No abstract available.
Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study.
Fourati S, Reslan A, Bourret J, Casalegno JS, Rahou Y, Chollet L, Pillet S, Tremeaux P, Dossou NC, Gault E, Salmona M, Imbert-Marcille BM, Mirand A, Larrat S, Moisan A, Marot S, Schnuriger A, Veyrenche N, Engelmann I, Handala L, Henry A, Stephan V, Brichler S, Avettand-Fenoel V, Zemali N, Lefeuvre C, Pronier C, Deroche L, Jaffar-Bandjee MC, Mouna L, Francois C, Regueme A, Hartard C, Rogez S, Gallais F, Ly A, Rodriguez C, Dos Santos G, Simon-Loriere E, Schwartz O, Buchrieser J, Pawlotsky JM, Lemoine F, Audureau E, Rameix-Welti MA; POLYRES investigators. Fourati S, et al. Among authors: salmona m. Lancet Infect Dis. 2024 Oct 14:S1473-3099(24)00570-X. doi: 10.1016/S1473-3099(24)00570-X. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39419046
Evaluation of the COVID-19 IgG/IgM Rapid Test from Orient Gene Biotech.
Dellière S, Salmona M, Minier M, Gabassi A, Alanio A, Le Goff J, Delaugerre C, Chaix ML; Saint-Louis CORE (COvid REsearch) group. Dellière S, et al. Among authors: salmona m. J Clin Microbiol. 2020 Jul 23;58(8):e01233-20. doi: 10.1128/JCM.01233-20. Print 2020 Jul 23. J Clin Microbiol. 2020. PMID: 32518071 Free PMC article.
[Which drugs to treat Adenovirus infections?].
Salmona M, Feghoul L, LeGoff J. Salmona M, et al. Virologie (Montrouge). 2021 Feb 1;25(1):43-56. doi: 10.1684/vir.2021.0883. Virologie (Montrouge). 2021. PMID: 33650496 French.
Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021.
Gaymard A, Bosetti P, Feri A, Destras G, Enouf V, Andronico A, Burrel S, Behillil S, Sauvage C, Bal A, Morfin F, Van Der Werf S, Josset L; ANRS MIE AC43 COVID-19; French viro COVID group; Blanquart F, Coignard B, Cauchemez S, Lina B. Gaymard A, et al. Euro Surveill. 2021 Mar;26(9):2100133. doi: 10.2807/1560-7917.ES.2021.26.9.2100133. Euro Surveill. 2021. PMID: 33663644 Free PMC article.
516 results